Brooke Rohlfing
Acute Care · Carmel, INNPI 1326771031
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,455 of the $2,973 with a category attached, or 82.6%. 22 manufacturers reported payments, led by Abbott at 29.0% of the total. 2025 is the largest year on record at $1,188, more than ten times the $26 reported in 2022.
Across 82 payments — averaging $36.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$862
- AstraZeneca$665
- E.r. Squibb & Sons, L.L.C.$307
- Cvrx, Inc.$173
- Kiniksa Pharmaceuticals International, PLC$142
- Pfizer$139
- plus $686 from 16 others
What the payments were for
- Travel & lodging$45515%
- Food & beverage$2,45583%
- Education$622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $862 |
| AstraZeneca | 19 | $665 |
| E.r. Squibb & Sons, L.L.C. | 6 | $307 |
| Cvrx, Inc. | 4 | $173 |
| Kiniksa Pharmaceuticals International, PLC | 9 | $142 |
| Pfizer | 2 | $139 |
| Johnson & Johnson(2 entities) | 2 | $132 |
| Abiomed | 4 | $98 |
| Novartis | 3 | $82 |
| Merck | 4 | $69 |
| Boehringer Ingelheim | 4 | $64 |
| Actelion Pharmaceuticals US, Inc. | 3 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $20 |
| Bayer | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Chiesi USA, Inc. | 1 | $13 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$681
- CAMZYOS$259
- FARXIGA$232
- VYNDAQEL$124
- Barostim Neo System$122
- VISTASEAL$113
- EVARREST$113
- ETHICON$113
- SURGIFLO Hemostatic Matrix$113
How this compares
$2,973 in reported general payments places this provider in the 85th percentile of 240 acute care providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 43 | $25,570 |
| JardianceEmpagliflozin | 11 | $9,338 |
| Torsemide | 88 | $1,778 |
| Metoprolol Succinate | 33 | $201 |
| Potassium Chloride | 18 | $191 |
| Isosorbide Dinitrate | 15 | $180 |
| Hydralazine Hcl | 15 | $124 |
| Furosemide | 32 | $79 |
| Losartan Potassium | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $82 | $25,57043 claims |
| Boehringer IngelheimJardiance | $64 | $9,33811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 240 acute care providers in Indiana.
Other acute care in Carmel
- Patricia VaughnCarmel$3K
- Walter ManderyCarmel$2K
- Melissa LorenzJeffersonville$19K
- Amara Wright-TerryMunster$17K
- Wen CaiNewburgh$12K
- Erin BarthSouth Bend$10K
- Sarah LongNewburgh$8K
- Aaron HoldermanNewburgh$8K
- Lauren ArmingtonIndianapolis$7K
- Ashley HillIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.